Logo image of MDV

MODIV INDUSTRIAL INC (MDV) Stock Fundamental Analysis

NYSE:MDV - New York Stock Exchange, Inc. - US60784B1017 - REIT - Currency: USD

14.55  -0.1 (-0.68%)

After market: 14.55 0 (0%)

Fundamental Rating

4

MDV gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 129 industry peers in the Diversified REITs industry. MDV has only an average score on both its financial health and profitability. MDV is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year MDV has reported negative net income.
MDV had a positive operating cash flow in the past year.
MDV had negative earnings in each of the past 5 years.
In the past 5 years MDV always reported a positive cash flow from operatings.
MDV Yearly Net Income VS EBIT VS OCF VS FCFMDV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M -60M -80M -100M

1.2 Ratios

MDV's Return On Assets of -0.10% is on the low side compared to the rest of the industry. MDV is outperformed by 61.90% of its industry peers.
MDV's Return On Equity of -0.28% is on the low side compared to the rest of the industry. MDV is outperformed by 61.90% of its industry peers.
MDV's Return On Invested Capital of 2.83% is in line compared to the rest of the industry. MDV outperforms 53.97% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MDV is in line with the industry average of 3.11%.
The last Return On Invested Capital (2.83%) for MDV is above the 3 year average (1.33%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.1%
ROE -0.28%
ROIC 2.83%
ROA(3y)-1.28%
ROA(5y)-3.36%
ROE(3y)-4.12%
ROE(5y)-9.95%
ROIC(3y)1.33%
ROIC(5y)1.07%
MDV Yearly ROA, ROE, ROICMDV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 -10 -20 -30

1.3 Margins

Looking at the Operating Margin, with a value of 37.87%, MDV belongs to the top of the industry, outperforming 84.13% of the companies in the same industry.
In the last couple of years the Operating Margin of MDV has declined.
MDV's Gross Margin of 92.74% is amongst the best of the industry. MDV outperforms 94.44% of its industry peers.
In the last couple of years the Gross Margin of MDV has grown nicely.
Industry RankSector Rank
OM 37.87%
PM (TTM) N/A
GM 92.74%
OM growth 3Y26.38%
OM growth 5Y-1.81%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.82%
GM growth 5Y1.58%
MDV Yearly Profit, Operating, Gross MarginsMDV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MDV is destroying value.
MDV has more shares outstanding than it did 1 year ago.
MDV has more shares outstanding than it did 5 years ago.
The debt/assets ratio for MDV is higher compared to a year ago.
MDV Yearly Shares OutstandingMDV Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
MDV Yearly Total Debt VS Total AssetsMDV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

2.2 Solvency

Based on the Altman-Z score of 0.10, we must say that MDV is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.10, MDV is doing worse than 76.98% of the companies in the same industry.
MDV has a debt to FCF ratio of 33.91. This is a negative value and a sign of low solvency as MDV would need 33.91 years to pay back of all of its debts.
MDV has a Debt to FCF ratio of 33.91. This is comparable to the rest of the industry: MDV outperforms 59.52% of its industry peers.
A Debt/Equity ratio of 1.50 is on the high side and indicates that MDV has dependencies on debt financing.
MDV's Debt to Equity ratio of 1.50 is on the low side compared to the rest of the industry. MDV is outperformed by 64.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.5
Debt/FCF 33.91
Altman-Z 0.1
ROIC/WACC0.41
WACC6.9%
MDV Yearly LT Debt VS Equity VS FCFMDV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M

2.3 Liquidity

A Current Ratio of 3.97 indicates that MDV has no problem at all paying its short term obligations.
The Current ratio of MDV (3.97) is better than 91.27% of its industry peers.
A Quick Ratio of 3.97 indicates that MDV has no problem at all paying its short term obligations.
MDV has a Quick ratio of 3.97. This is amongst the best in the industry. MDV outperforms 91.27% of its industry peers.
Industry RankSector Rank
Current Ratio 3.97
Quick Ratio 3.97
MDV Yearly Current Assets VS Current LiabilitesMDV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 77.24% over the past year.
Looking at the last year, MDV shows a decrease in Revenue. The Revenue has decreased by -6.43% in the last year.
MDV shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.16% yearly.
EPS 1Y (TTM)77.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.85%
Revenue 1Y (TTM)-6.43%
Revenue growth 3Y6.7%
Revenue growth 5Y21.16%
Sales Q2Q%-6.76%

3.2 Future

MDV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.71% yearly.
Based on estimates for the next years, MDV will show a small growth in Revenue. The Revenue will grow by 2.53% on average per year.
EPS Next Y105.44%
EPS Next 2Y34.18%
EPS Next 3Y24.71%
EPS Next 5YN/A
Revenue Next Year-1.83%
Revenue Next 2Y0.14%
Revenue Next 3Y2.53%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MDV Yearly Revenue VS EstimatesMDV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M 50M
MDV Yearly EPS VS EstimatesMDV Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.5 -1 -1.5

2

4. Valuation

4.1 Price/Earnings Ratio

MDV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year MDV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MDV Price Earnings VS Forward Price EarningsMDV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MDV is valued a bit cheaper than 71.43% of the companies in the same industry.
78.57% of the companies in the same industry are more expensive than MDV, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 17.02
EV/EBITDA 12.01
MDV Per share dataMDV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

MDV's earnings are expected to grow with 24.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.18%
EPS Next 3Y24.71%

4

5. Dividend

5.1 Amount

MDV has a Yearly Dividend Yield of 7.85%, which is a nice return.
MDV's Dividend Yield is rather good when compared to the industry average which is at 18.40. MDV pays more dividend than 82.54% of the companies in the same industry.
MDV's Dividend Yield is rather good when compared to the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 7.85%

5.2 History

MDV has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years2
MDV Yearly Dividends per shareMDV Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

The earnings of MDV are negative and hence is the payout ratio. MDV will probably not be able to sustain this dividend level.
DP-2614.05%
EPS Next 2Y34.18%
EPS Next 3Y24.71%
MDV Yearly Income VS Free CF VS DividendMDV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M -60M -80M -100M

MODIV INDUSTRIAL INC

NYSE:MDV (2/21/2025, 8:04:01 PM)

After market: 14.55 0 (0%)

14.55

-0.1 (-0.68%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)11-06 2024-11-06/bmo
Earnings (Next)03-04 2025-03-04/amc
Inst Owners15.42%
Inst Owner Change42.07%
Ins Owners3.19%
Ins Owner Change1.25%
Market Cap140.41M
Analysts85.71
Price Target18.53 (27.35%)
Short Float %0.32%
Short Ratio0.85
Dividend
Industry RankSector Rank
Dividend Yield 7.85%
Yearly Dividend1.56
Dividend Growth(5Y)N/A
DP-2614.05%
Div Incr Years1
Div Non Decr Years2
Ex-Date03-31 2025-03-31 (0.0975)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-267.33%
Min EPS beat(2)-694.06%
Max EPS beat(2)159.41%
EPS beat(4)2
Avg EPS beat(4)-290.92%
Min EPS beat(4)-1618.15%
Max EPS beat(4)989.11%
EPS beat(8)4
Avg EPS beat(8)-12.09%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.51%
Min Revenue beat(2)-4.05%
Max Revenue beat(2)1.02%
Revenue beat(4)1
Avg Revenue beat(4)-1.93%
Min Revenue beat(4)-4.05%
Max Revenue beat(4)1.02%
Revenue beat(8)4
Avg Revenue beat(8)5.66%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.11%
PT rev (3m)2.35%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-333.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-74.29%
Revenue NQ rev (1m)-1.51%
Revenue NQ rev (3m)-1.62%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.77%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.97
P/FCF 17.02
P/OCF 7.71
P/B 0.75
P/tB 0.76
EV/EBITDA 12.01
EPS(TTM)-0.28
EYN/A
EPS(NY)-0.33
Fwd EYN/A
FCF(TTM)0.85
FCFY5.88%
OCF(TTM)1.89
OCFY12.96%
SpS4.9
BVpS19.3
TBVpS19.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.1%
ROE -0.28%
ROCE 3.58%
ROIC 2.83%
ROICexc 2.87%
ROICexgc 2.88%
OM 37.87%
PM (TTM) N/A
GM 92.74%
FCFM 17.43%
ROA(3y)-1.28%
ROA(5y)-3.36%
ROE(3y)-4.12%
ROE(5y)-9.95%
ROIC(3y)1.33%
ROIC(5y)1.07%
ROICexc(3y)1.38%
ROICexc(5y)1.11%
ROICexgc(3y)1.41%
ROICexgc(5y)1.15%
ROCE(3y)1.69%
ROCE(5y)1.37%
ROICexcg growth 3Y20.93%
ROICexcg growth 5Y2.23%
ROICexc growth 3Y23.09%
ROICexc growth 5Y2.13%
OM growth 3Y26.38%
OM growth 5Y-1.81%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.82%
GM growth 5Y1.58%
F-Score6
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 1.5
Debt/FCF 33.91
Debt/EBITDA 8.11
Cap/Depr 60.01%
Cap/Sales 21.04%
Interest Coverage 1.34
Cash Conversion 52.75%
Profit Quality N/A
Current Ratio 3.97
Quick Ratio 3.97
Altman-Z 0.1
F-Score6
WACC6.9%
ROIC/WACC0.41
Cap/Depr(3y)603.42%
Cap/Depr(5y)417.25%
Cap/Sales(3y)200.21%
Cap/Sales(5y)142.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)77.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.85%
EPS Next Y105.44%
EPS Next 2Y34.18%
EPS Next 3Y24.71%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.43%
Revenue growth 3Y6.7%
Revenue growth 5Y21.16%
Sales Q2Q%-6.76%
Revenue Next Year-1.83%
Revenue Next 2Y0.14%
Revenue Next 3Y2.53%
Revenue Next 5YN/A
EBIT growth 1Y78.47%
EBIT growth 3Y34.85%
EBIT growth 5Y18.96%
EBIT Next Year939.49%
EBIT Next 3Y129.91%
EBIT Next 5YN/A
FCF growth 1Y106.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y42.77%
OCF growth 3Y43.76%
OCF growth 5Y23.04%